Related Experiment Video
Updated: Feb 3, 2026

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
Published on: October 10, 2020
Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics
Chiranjeev Sharma1, Young Ho Seo2
1College of Pharmacy, Keimyung University, Daegu 42601, Korea. 1chiranjeevsharma1@gmail.com.
Abstract:
Targeted therapy is an emerging paradigm in the development of next-generation anticancer drugs. Heat shock factor 1 (HSF1) has been identified as a promising drug target because it regulates several pathways responsible for cancer cell growth, metastasis, and survival. Studies have clearly demonstrated that HSF1 is an effective drug target. Herein, we provide a concise yet comprehensive and integrated overview of progress in developing small molecule inhibitors of HSF1 as next-generation anticancer chemotherapeutics while critically evaluating their potential and challenges. We believe that this review will provide a better understanding of important concepts helpful for outlining the strategy to develop new chemotherapeutic agents with promising anticancer activities by targeting HSF1.
Insights
Targeting Heat Shock Factor 1 (HSF1) with small molecule inhibitors shows promise for next-generation cancer therapies. This review details progress and challenges in developing these anticancer drugs by targeting HSF1 pathways.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Heat Shock Factor 1 (HSF1) is crucial for cancer cell growth, metastasis, and survival.
- HSF1 is a validated and promising drug target for anticancer therapies.
Purpose of the Study:
- To provide a comprehensive overview of small molecule inhibitors targeting HSF1.
- To critically evaluate the potential and challenges of HSF1-targeted anticancer drugs.
Main Methods:
- Literature review of studies on HSF1 inhibitors.
- Analysis of HSF1's role in cancer pathways.
- Evaluation of drug development progress and challenges.
Main Results:
- HSF1 regulates key cancer pathways, confirming its viability as a drug target.
- Significant progress has been made in developing small molecule inhibitors for HSF1.
Conclusions:
- Targeting HSF1 represents a promising strategy for developing novel anticancer chemotherapeutics.
- Further research is needed to overcome challenges and optimize HSF1-targeted drug development.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Thermodynamics: Chemical Potential and Activity
The thermodynamic equilibrium constant is more accurately defined in terms of activity rather than concentration.
Generation of Action Potential in Skeletal Muscles
Like neurons, muscle cells are also regarded as excitable due to their capacity to change in response to stimuli, primarily due to voltage-gated ion channels embedded in their plasma membranes, which get activated by alterations in the...
Molecules and Compounds
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

